| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 07/08/2009 | CN100509783C Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509058C Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/08/2009 | CN100509055C Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/08/2009 | CN100508955C Effervesce tablet of American ginseng containing vitamin C and preparation method thereof |
| 07/07/2009 | US7557183 Polyethylene glycol linked GLP-1 compounds |
| 07/07/2009 | US7557146 Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same |
| 07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 07/07/2009 | US7557112 Aromatic-ring-fused pyrimidine derivative |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7556926 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2422711C Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2286098C Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 07/02/2009 | WO2009082346A1 New acetyl coenzyme a carboxylase (acc) inhibitors and uses in treatments of obesity and diabetes mellitus - 087 |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081782A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/02/2009 | WO2009081195A1 Carbamoyl compounds as dgat1 inhibitors 190 |
| 07/02/2009 | WO2009080693A2 Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker |
| 07/02/2009 | WO2009080691A2 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
| 07/02/2009 | WO2009080223A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | WO2009080198A1 Fused cynopryridines and the use thereof |
| 07/02/2009 | WO2009080197A1 Substituted pyrrolo[2, 3-b] and pyrazolo[3, 4-b] pyridines for use as adenosine receptor ligands |
| 07/02/2009 | WO2009080033A1 Compressed chewing gum comprising metformin |
| 07/02/2009 | WO2009080032A1 Compressed chewing gum comprising a systemically active small peptide |
| 07/02/2009 | WO2009080025A1 Compressed chewing gum comprising metformin |
| 07/02/2009 | WO2009080024A1 Compressed chewing gum comprising an incretin mimetic |
| 07/02/2009 | WO2009079921A1 Cucurbitane triterpenoid saponins, pharmaceutical composition thereof, preparation and use thereof |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079860A1 Medicament for treating obesity or fatty liver disease |
| 07/02/2009 | WO2009079765A1 Compounds with activity at the 5-ht2c receptor |
| 07/02/2009 | WO2009063364A3 Modulators of urotensin receptor and methods of use thereof |
| 07/02/2009 | WO2009061445A3 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 07/02/2009 | WO2009058944A3 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and /or nf- kappa b activity and use thereof |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009036149A9 Methods for treatment of degenerative disease associated with apoptosis |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008155403A3 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases |
| 07/02/2009 | WO2008153632A3 Compositions and methods for treating obesity and related disorders |
| 07/02/2009 | WO2008068424A8 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/02/2009 | US20090170949 Method To Control Body Weight |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170913 Novel mch receptor antagonists |
| 07/02/2009 | US20090170908 Spiro compounds and pharmaceutical use thereof |
| 07/02/2009 | US20090170900 Dosing regimen for weight loss |
| 07/02/2009 | US20090170895 S1p3 receptor antagonist |
| 07/02/2009 | US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application |
| 07/02/2009 | US20090170891 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170864 (S)-3-{5-[(1-Pyridin-2-yl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid ethyl ester; obesity, type II diabetes mellitus and metabolic syndrome |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170838 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170829 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 07/02/2009 | US20090170828 Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 07/02/2009 | US20090170799 Chimeric oligonucleotide for use in diagnosis and treatment of tissue destruction, necrosis and inflammatory diseases |
| 07/02/2009 | US20090170778 PYY Agonists and Uses Thereof |
| 07/02/2009 | US20090170777 Hsp therapy in conjunction with a low antigenicity diet |
| 07/02/2009 | US20090170775 Vasoactive intestinal polypeptide compositions |
| 07/02/2009 | US20090170773 Novel use of g-protein-conjugated receptor and ligand thereof |
| 07/02/2009 | US20090170772 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170761 Sustained release preparation of pro-insulin c-peptide |
| 07/02/2009 | US20090170756 Chimeric natriuretic peptides |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169700 Healthy Food Product |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169490 Composition and method for weight loss |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/02/2009 | CA2710441A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | CA2709861A1 Pharmaceutical compositions |
| 07/02/2009 | CA2709530A1 Monosebacate of pyrazole derivative |
| 07/02/2009 | CA2708372A1 Carboxyl- or hydroxylsubstituted benzimidazole derivatives |
| 07/02/2009 | CA2707660A1 Carbamoyl compounds as dgat1 inhibitors 190 |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/02/2009 | CA2707403A1 N-pyrazole-2-pyridinecarboxamide derivative |